Mark Novara

Mark Novara

Executive Vice President, Chief Commercial OfficeratTandem Diabetes Care· In proxies 2023–2025

Pay in FY2025+175% from the year before · Tandem Diabetes Care stock -39.0% the same year

Mark Novara was paid $2.2M in FY2025 (Dec), up 175%. Tandem Diabetes Care stock fell 39.0% that year.

Pay$100 in the stock at the end of FY22 → $49
Pay is from the Summary Compensation Table of each Tandem Diabetes Care proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tandem Diabetes CarePublic company · 3 yr
    • Executive Vice President, Chief Commercial Officer2023 – Present · 3 yrStock in role -53%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?